Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc.. Read the official filing
No signal scores available.
Norman Sharpless appears in our data through filings on G1 Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 15 June 2023 and the latest from 18 September 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 September 2024 came the latest disclosure, a transaction in G1 Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations